Fundraising FoxEpiEndo
Reykjavik, IS · 1 known investors
Find your way into EpiEndo
Sign up to see every warm intro you have to EpiEndo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EpiEndo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for chronic respiratory diseases such as COPD, based on research into macrolides and their effects on the lung epithelium. Its lead program, EP395 (glasmacinal), is a non-antibacterial macrolide with anti-inflammatory activity that is Phase 2b ready.
Investors · 1
In the news
Frequently asked questions
- What does EpiEndo do?
- EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for chronic respiratory diseases such as COPD, based on research into macrolides and their effects on the lung epithelium. Its lead program, EP395 (glasmacinal), is a non-antibacterial macrolide with anti-inflammatory activity that is Phase 2b ready.
- Who are EpiEndo's investors?
- EpiEndo's investors include Brunnur Ventures GP.
- Where is EpiEndo headquartered?
- EpiEndo is headquartered in Reykjavik, IS.